JP2008163011A - Germicidal compound and germicidal composition - Google Patents

Germicidal compound and germicidal composition Download PDF

Info

Publication number
JP2008163011A
JP2008163011A JP2007311841A JP2007311841A JP2008163011A JP 2008163011 A JP2008163011 A JP 2008163011A JP 2007311841 A JP2007311841 A JP 2007311841A JP 2007311841 A JP2007311841 A JP 2007311841A JP 2008163011 A JP2008163011 A JP 2008163011A
Authority
JP
Japan
Prior art keywords
compound
acid
bactericidal
germicidal
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007311841A
Other languages
Japanese (ja)
Other versions
JP5207716B2 (en
Inventor
Takeshi Kobayashi
剛 小林
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SK Kaken Co Ltd
Original Assignee
SK Kaken Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SK Kaken Co Ltd filed Critical SK Kaken Co Ltd
Priority to JP2007311841A priority Critical patent/JP5207716B2/en
Publication of JP2008163011A publication Critical patent/JP2008163011A/en
Application granted granted Critical
Publication of JP5207716B2 publication Critical patent/JP5207716B2/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To provide a germicidal compound having germicidal properties comparable to those of conventional germicidal compounds, having high safety and being readily handleable. <P>SOLUTION: The germicidal compound is an N-alkyl-modified phenylimidazole compound in which carbon number of the alkyl group is ≥5, preferably 6-12. <P>COPYRIGHT: (C)2008,JPO&INPIT

Description

本発明は、安全性が高く、取扱いが容易な殺菌性化合物、及びその殺菌性化合物を含む殺菌性組成物に関するものである。   The present invention relates to a bactericidal compound that is highly safe and easy to handle, and a bactericidal composition containing the bactericidal compound.

従来、塗料、接着剤、澱粉糊、にかわ、合成ゴムラテックス、セメント混和液等の産業製品には、細菌、カビ、酵母等の微生物が繁殖しやすく、品質の劣化や悪臭の発生等の原因となっている。そこで、これをコントロールするために、防腐剤、防カビ剤等の殺菌剤が使用されている。殺菌剤としては種々の化合物が知られているが、その中でも、特にイソチアゾリン化合物は、幅広い抗菌スペクトル有するため、各種産業分野において広く使用されている。例えば、特許文献1には、チオフェン系化合物及びイソチアゾリン系化合物を含有する工業用殺菌組成物が記載されている。   Traditionally, industrial products such as paints, adhesives, starch pastes, glue, synthetic rubber latex, cement admixtures, etc., are prone to the growth of microorganisms such as bacteria, mold, yeast, etc. It has become. In order to control this, bactericides such as preservatives and fungicides are used. Various compounds are known as bactericides. Among them, isothiazoline compounds are particularly widely used in various industrial fields because they have a broad antibacterial spectrum. For example, Patent Document 1 describes an industrial bactericidal composition containing a thiophene compound and an isothiazoline compound.

しかしながら、イソチアゾリン化合物は、イソチアゾリン環の開裂により生成する反応種が、タンパク等に結合することで殺菌性を発揮するというメカニズムを有するものである。そのため、しばしばこれを取り扱う従事者が、皮膚にアレルギー反応を引き起こすおそれがある。   However, the isothiazoline compound has a mechanism in which a reactive species produced by cleavage of the isothiazoline ring exhibits bactericidal properties by binding to a protein or the like. As a result, workers who often handle this may cause an allergic reaction to the skin.

本発明は、このような問題点に鑑みなされたものであり、従来品に匹敵する殺菌性を有するとともに、安全性が高く、取扱いが容易な殺菌性化合物を提供することを目的とするものである。   The present invention has been made in view of such problems, and aims to provide a bactericidal compound that has bactericidal properties comparable to conventional products, is highly safe, and is easy to handle. is there.

特開2003−55110号公報JP 200355110 A

本発明者は、上記目的を達成するため鋭意検討を行った結果、殺菌成分として、フェニルイミダゾールを母体とし、そのN位(1位)を特定鎖長のアルキル基で変性した化合物が有効であることを見出し、本発明を完成させるに到った。   As a result of intensive studies to achieve the above object, the present inventor is effective to use a compound in which phenylimidazole is used as a base and the N-position (position 1) is modified with an alkyl group having a specific chain length as a bactericidal component. As a result, the present invention has been completed.

すなわち、本発明は以下の特徴を有するものである。
1.フェニルイミダゾール化合物のN−アルキル変性物であり、当該アルキル基の炭素数が5以上であることを特徴とする殺菌性化合物。
2.前記アルキル基の炭素数が6〜12である項1.記載の殺菌性化合物。
3.項1.または項2.記載の殺菌性化合物を有効成分として含む殺菌性組成物。
That is, the present invention has the following characteristics.
1. A bactericidal compound, which is an N-alkyl modified product of a phenylimidazole compound, wherein the alkyl group has 5 or more carbon atoms.
2. Claim | item 1 whose carbon number of the said alkyl group is 6-12. The bactericidal compound as described.
3. Item 1. Or item 2. A bactericidal composition comprising the described bactericidal compound as an active ingredient.

本発明の殺菌性化合物は、従来品に匹敵する殺菌性を発揮することができる。しかも、本発明の殺菌性化合物は、安全性が高く、皮膚炎症等を引き起こし難く、取扱いが容易である。   The bactericidal compound of the present invention can exhibit bactericidal properties comparable to conventional products. Moreover, the bactericidal compound of the present invention is highly safe, hardly causes skin irritation, and is easy to handle.

以下、本発明を実施するための最良の形態について説明する。   Hereinafter, the best mode for carrying out the present invention will be described.

本発明の殺菌性化合物は、フェニルイミダゾール化合物のN−アルキル変性物であり、当該アルキル基の炭素数が5以上である化合物である。このような本発明化合物は、優れた殺菌性を発揮するとともに、安全性が高く、取扱いも容易である。   The bactericidal compound of the present invention is an N-alkyl modified product of a phenylimidazole compound, and is a compound in which the alkyl group has 5 or more carbon atoms. Such a compound of the present invention exhibits excellent bactericidal properties, is highly safe, and is easy to handle.

本発明の殺菌性化合物の母体となる化合物は、フェニルイミダゾール化合物である。このような化合物は、イミダゾール環にフェニル基を有するものであり、本発明では特に、[化1]に示すようにイミダゾール環の2位にフェニル基を有するものが好適である。なお、本発明の効果が阻害されない範囲内であれば、イミダゾール環及び/またはフェニル基の一部に置換基を有するものも使用可能である。   The compound that is the base of the bactericidal compound of the present invention is a phenylimidazole compound. Such a compound has a phenyl group in the imidazole ring, and in the present invention, a compound having a phenyl group at the 2-position of the imidazole ring as shown in [Chemical Formula 1] is particularly preferable. In addition, as long as the effect of this invention is not inhibited, what has a substituent in a part of imidazole ring and / or a phenyl group can also be used.

Figure 2008163011
Figure 2008163011

本発明の殺菌性化合物は、[化2]に示すように、上記フェニルイミダゾール化合物のN位(1位)に、炭素数5以上のアルキル基(−R)を有するものである。   As shown in [Chemical Formula 2], the bactericidal compound of the present invention has an alkyl group (—R) having 5 or more carbon atoms at the N-position (1-position) of the phenylimidazole compound.

Figure 2008163011
Figure 2008163011

N位(1位)がアルキル変性されていない化合物では、微生物の細胞膜中におけるリン脂質との疎水性相互作用が小さいか、もしくは、細胞内の酵素に基質として認識されないために酵素阻害が起きず、十分な殺菌性が得られない。
また、アルキル基の炭素数が5未満である場合は、殺菌性において満足な性能を得ることができない。本発明において、このアルキル基の炭素数は5以上であることが必須であるが、好ましくは6〜12、より好ましくは7〜10、さらに好ましくは7〜9である。アルキル基の炭素数がこのような範囲内であれば、より広範な種類の微生物に対して、安定した殺菌効果を発現することが可能となる。
上記アルキル基は、直鎖アルキル基、分岐アルキル基のいずれであってもよいが、本発明では直鎖アルキル基が好適である。
Compounds that are not alkyl-modified at the N-position (position 1) have little hydrophobic interaction with phospholipids in the cell membrane of microorganisms, or are not recognized as substrates by enzymes in the cells, so enzyme inhibition does not occur A sufficient bactericidal property cannot be obtained.
Moreover, when the carbon number of the alkyl group is less than 5, satisfactory performance in bactericidal properties cannot be obtained. In the present invention, it is essential that the alkyl group has 5 or more carbon atoms, preferably 6 to 12, more preferably 7 to 10, and further preferably 7 to 9. If the carbon number of the alkyl group is within such a range, a stable bactericidal effect can be expressed against a wider variety of microorganisms.
The alkyl group may be either a linear alkyl group or a branched alkyl group, but a linear alkyl group is preferred in the present invention.

本発明殺菌性化合物は、フェニルイミダゾール化合物のN−アルキル化により製造することができる。例えば、非プロトン性極性溶媒中にフェニルイミダゾールを溶解し、アルカリを加え、加熱を開始する。フェニルイミダゾールが脱プロトン化されたところに、1位炭素に脱離基を有するアルキル化合物を滴下し、滴下終了後、還流させながら約5時間反応させる。反応停止後に、生成する塩を除去し、さらに溶媒を蒸留法により除去することで、粗精製の目的化合物を製造することができる。さらに公知の方法により、精製を行うことで、高純度の目的化合物が得られる。   The bactericidal compound of the present invention can be produced by N-alkylation of a phenylimidazole compound. For example, phenylimidazole is dissolved in an aprotic polar solvent, alkali is added, and heating is started. When phenylimidazole is deprotonated, an alkyl compound having a leaving group at the 1-position carbon is dropped, and after completion of the dropping, the reaction is carried out for about 5 hours while refluxing. After stopping the reaction, the produced salt is removed, and the solvent is further removed by distillation, whereby the target compound for crude purification can be produced. Further, the target compound with high purity can be obtained by purification by a known method.

本発明の殺菌性化合物は、塩として存在するものであってもよい。本発明の殺菌性化合物が塩であれば、水への溶解性向上、結晶性の向上等を図ることができ、当該化合物を水溶液、粉末、粒状等の各種形態に製剤化する際に有効である。カビ等の至適pH2〜8.5の範囲内において、当該化合物の溶解性を高めることも可能である。
また、本発明化合物を塩とした場合、イミダゾール環の窒素原子上の非共有電子対にプロトンが配位し、分子が陽電荷を帯びた状態になるものと考えられる。当該化合物の多くが陽イオンとして存在することにより、微生物を構成するリン脂質やタンパク質との相互作用が高まり、殺菌効果が向上することも期待できる。
このような塩は、[化3]に示す構造で表すことができる。なお、Xn−は有機性または無機性のアニオン基であり、nは整数である。
The bactericidal compound of the present invention may exist as a salt. If the bactericidal compound of the present invention is a salt, it can improve solubility in water, improve crystallinity, etc., and is effective in formulating the compound into various forms such as aqueous solutions, powders, and granules. is there. It is also possible to increase the solubility of the compound within the optimum pH range of 2 to 8.5 such as mold.
In addition, when the compound of the present invention is used as a salt, it is considered that a proton is coordinated to an unshared electron pair on the nitrogen atom of the imidazole ring, and the molecule becomes positively charged. When many of the compounds are present as cations, the interaction with phospholipids and proteins constituting microorganisms is increased, and the bactericidal effect can be expected to be improved.
Such a salt can be represented by the structure shown in [Chemical Formula 3]. X n− is an organic or inorganic anionic group, and n is an integer.

Figure 2008163011
Figure 2008163011

有機性アニオン基を与える酸としては、例えば、酢酸、アジピン酸、アスコルビン酸、安息香酸、ベンゼンスルホン酸、酪酸、樟脳酸、樟脳スルホン酸、クエン酸、シクロヘキシルスルファミン酸、エタンスルホン酸、フマル酸、グルタミン酸、2−ヒドロキシエチルスルホン酸、ヘプタン酸、ヘキサン酸、ヒドロキシマレイン酸、乳酸、リンゴ酸、マレイン酸、メタンスルホン酸、2−ナフタレンスルホン酸、蓚酸、パモ酸、フェニル酢酸、ピバリン酸、プロピオン酸、サリチル酸、ステアリン酸、コハク酸、酒石酸、トシル酸、ウンデカン酸、アスパラギン酸等が挙げられる。また、無機性アニオン基を与える酸としては、塩酸、硫酸、硝酸、重炭酸、重硫酸、臭化水素酸、過硫酸、リン酸、2リン酸、ヨウ化水素酸等が挙げられる。 Examples of the acid that gives an organic anionic group include acetic acid, adipic acid, ascorbic acid, benzoic acid, benzenesulfonic acid, butyric acid, camphoric acid, camphorsulfonic acid, citric acid, cyclohexylsulfamic acid, ethanesulfonic acid, fumaric acid, Glutamic acid, 2-hydroxyethylsulfonic acid, heptanoic acid, hexanoic acid, hydroxymaleic acid, lactic acid, malic acid, maleic acid, methanesulfonic acid, 2-naphthalenesulfonic acid, succinic acid, pamoic acid, phenylacetic acid, pivalic acid, propionic acid , Salicylic acid, stearic acid, succinic acid, tartaric acid, tosylic acid, undecanoic acid, aspartic acid and the like. Examples of the acid that gives an inorganic anionic group include hydrochloric acid, sulfuric acid, nitric acid, bicarbonate, bisulfuric acid, hydrobromic acid, persulfuric acid, phosphoric acid, diphosphoric acid, and hydroiodic acid.

これらの酸により得られる塩の中でも、薬学上許容される、メタンスルホン酸塩、エタンスルホン酸塩、ベンゼンスルホン酸塩、トシル酸塩、蓚酸塩、酒石酸塩、クエン酸塩、マレイン酸塩、コハク酸塩、酢酸塩、安息香酸塩、アスコルビン酸塩、乳酸塩、リンゴ三酸塩、グルタミン酸塩、アスパラギン酸塩、塩酸塩、臭化水素酸塩、ヨウ化水素酸塩、リン酸塩、硫酸塩、硝酸塩等であれば安全性が高くなる。特に、これらの中でも塩酸塩、臭化水素酸塩、リン酸塩、硫酸塩、メタンスルホン酸塩、トシル酸塩、蓚酸塩、酒石酸塩、クエン酸塩、酢酸塩、乳酸塩、グルタミン酸塩、アスパラギン酸塩等が好適である。
このような塩は、慣用的な化学合成法によって合成することができる。具体的には、水中または有機溶媒中、あるいはこれらの混合溶媒中において、1当量以上の酸とイミダゾール化合物を反応させる方法等により合成できる。この際、過剰な酸を真空下で除去してもよいし、イオン交換樹脂を用いてアニオン基を交換することも可能である。
Among the salts obtained by these acids, pharmaceutically acceptable methanesulfonate, ethanesulfonate, benzenesulfonate, tosylate, oxalate, tartrate, citrate, maleate, succinate Acid salt, acetate salt, benzoate salt, ascorbate salt, lactate salt, apple trisalt salt, glutamate salt, aspartate salt, hydrochloride salt, hydrobromide salt, hydroiodide salt salt, phosphate salt, sulfate salt Nitrate or the like increases safety. In particular, among these, hydrochloride, hydrobromide, phosphate, sulfate, methanesulfonate, tosylate, oxalate, tartrate, citrate, acetate, lactate, glutamate, asparagine Acid salts and the like are preferred.
Such salts can be synthesized by conventional chemical synthesis methods. Specifically, it can be synthesized by a method of reacting 1 equivalent or more of an acid and an imidazole compound in water or an organic solvent or a mixed solvent thereof. At this time, excess acid may be removed under vacuum, or an anion group may be exchanged using an ion exchange resin.

本発明の殺菌性化合物は、目的とする用途等に応じた形態で使用すればよく、例えば化合物自体をそのまま使用することもできるし、当該化合物を有効成分として含む殺菌性組成物として使用することもできる。本発明化合物を殺菌性組成物として使用する場合、その形態としては、殺菌性化合物を媒体に溶解ないし分散、乳化させた形態、あるいは殺菌性化合物、結合材、その他添加剤等を適宜混合した形態等が挙げられる。   The bactericidal compound of the present invention may be used in a form corresponding to the intended application, for example, the compound itself can be used as it is, or used as a bactericidal composition containing the compound as an active ingredient. You can also. When the compound of the present invention is used as a bactericidal composition, the form thereof is a form in which the bactericidal compound is dissolved, dispersed or emulsified in a medium, or a form in which bactericidal compounds, binders, other additives, etc. are appropriately mixed. Etc.

媒体としては、例えば、水、アルコール類、グリコール類、グリコールエーテル類等が挙げられる。結合材としては、例えば、セメント、石膏、水ガラス等の無機質結合材、酢酸ビニル樹脂、エポキシ樹脂、アクリル樹脂、ウレタン樹脂、アクリルシリコン樹脂、フッ素樹脂等の有機質結合材等が挙げられる。このような結合材を含む殺菌性組成物は、塗料として使用することができ、またシート材等の成形体用組成物等として使用することもできる。添加剤としては、例えば、顔料、骨材、繊維、造膜助剤、可塑剤、凍結防止剤、防腐剤、防黴剤、消泡剤、増粘剤、レベリング剤、pH調整剤、顔料分散剤、沈降防止剤、たれ防止剤、艶消し剤、紫外線吸収剤、光安定剤、酸化防止剤、吸着剤、架橋剤、触媒等が挙げられる。   Examples of the medium include water, alcohols, glycols, glycol ethers and the like. Examples of the binder include inorganic binders such as cement, gypsum, and water glass, and organic binders such as vinyl acetate resin, epoxy resin, acrylic resin, urethane resin, acrylic silicon resin, and fluorine resin. The bactericidal composition containing such a binder can be used as a paint, and can also be used as a composition for a molded article such as a sheet material. Examples of additives include pigments, aggregates, fibers, film-forming aids, plasticizers, antifreeze agents, antiseptics, antifungal agents, antifoaming agents, thickeners, leveling agents, pH adjusters, and pigment dispersions. Agents, anti-settling agents, anti-sagging agents, matting agents, ultraviolet absorbers, light stabilizers, antioxidants, adsorbents, crosslinking agents, catalysts and the like.

殺菌性組成物における殺菌性化合物の配合量は、適宜設定すればよい。殺菌性組成物を塗料等として用いる場合は、通常、殺菌性組成物中の殺菌性化合物の比率が10〜5000ppm(好ましくは100〜2000ppm)程度となるようにすればよい。   What is necessary is just to set the compounding quantity of the bactericidal compound in a bactericidal composition suitably. When the bactericidal composition is used as a paint or the like, the ratio of the bactericidal compound in the bactericidal composition is usually about 10 to 5000 ppm (preferably 100 to 2000 ppm).

以下に実施例を示し、本発明の特徴をより明確にする。   Examples are given below to clarify the features of the present invention.

(合成方法)
20mmolのフェニルイミダゾールを30mlのDMF(N,N−ジメチルホルムアミド)に溶解させ、さらに30mmolのナトリウムメトキシドを加え、窒素雰囲気下にて、加熱しながら攪拌した。溶液の色に変化が認められた後に、40mmolの臭化アルキルを滴下し、還流させながら5時間攪拌を行った。反応停止後、反応液をろ過し、沈殿物を除去した後に、減圧蒸留にて溶媒を留去した。残渣をシリカゲルカラムクロマトグラフィー(ジクロロメタン:メタノール=20:1)にて精製を行い、TLC(ジクロロメタン:メタノール=10:1)にて、スポットがRf=0.6〜0.8に現れる画分を集め、濃縮し、前記[化2]に示す殺菌性化合物を得た。
(Synthesis method)
20 mmol of phenylimidazole was dissolved in 30 ml of DMF (N, N-dimethylformamide), 30 mmol of sodium methoxide was further added, and the mixture was stirred with heating under a nitrogen atmosphere. After a change in the color of the solution was observed, 40 mmol of alkyl bromide was added dropwise and stirred for 5 hours while refluxing. After stopping the reaction, the reaction solution was filtered to remove the precipitate, and then the solvent was distilled off under reduced pressure. The residue is purified by silica gel column chromatography (dichloromethane: methanol = 20: 1), and the fraction in which the spot appears at Rf = 0.6 to 0.8 by TLC (dichloromethane: methanol = 10: 1). Collected and concentrated to obtain the bactericidal compound shown in [Chemical Formula 2].

なお、臭化アルキルとしては、炭素数4〜12の直鎖アルキルを有するものを用意し、それぞれの臭化アルキルを使用して上記合成方法により計8種の殺菌性化合物を製造した。   In addition, as alkyl bromide, what has a C4-C12 linear alkyl was prepared, and eight types of bactericidal compounds were manufactured with the said synthesis method using each alkyl bromide.

(試験方法)
上記方法で得られた8種の殺菌性化合物、及びOIT(2‐オクチル‐4‐イソチアゾリン‐3‐オン)について、以下の試験を実施し、殺菌性を評価した。
(Test method)
The following tests were conducted on the eight bactericidal compounds obtained by the above method and OIT (2-octyl-4-isothiazolin-3-one) to evaluate the bactericidal properties.

各殺菌性化合物を4mg/mlになるようにエタノールで溶解させた試験液を作成し、これを30mm×30mmに切断したろ紙の上に0.1ml滴下した。これを風乾し、試験片とした。
クロラムフェニコールを添加したポテトデキストロース寒天平板培地の中央に、上記試験片を静置した。次いで、スルホこはく酸ジオクチルナトリウム50mlを蒸留水に添加し、オートクレーブした滅菌水に、カビ胞子を5白金耳加え、ガーゼでろ過した胞子懸濁液を、上記寒天培地に1ml滴下し、28℃に設定したインキュベーターにて1週間培養を行った。カビ胞子としては、表1に示すものをそれぞれ使用した。
A test solution in which each bactericidal compound was dissolved in ethanol so as to be 4 mg / ml was prepared, and 0.1 ml of this was dropped on a filter paper cut into 30 mm × 30 mm. This was air-dried to obtain a test piece.
The said test piece was left still in the center of the potato dextrose agar plate culture medium which added chloramphenicol. Next, 50 ml of dioctyl sodium sulphosuccinate was added to distilled water, 5 mold spores were added to autoclaved sterilized water, and 1 ml of the spore suspension filtered with gauze was dropped into the agar medium at 28 ° C. Culture was performed for 1 week in the set incubator. As the mold spores, those shown in Table 1 were used.

培養後の状態を確認し、以下の基準にて評価を行った。結果を表2に示す。
◎:試験片上に菌糸の伸長が認められない
○:試験片の1/3未満に菌糸の伸長が認められる
△:試験片の1/3以上2/3未満に菌糸の伸長が認められる
×:試験片の2/3以上に菌糸の伸長が認められる
The state after culture was confirmed and evaluated according to the following criteria. The results are shown in Table 2.
A: No hyphal extension is observed on the test piece. O: Hypha extension is observed in less than 1/3 of the test piece. Δ: Hypha extension is observed in 1/3 or more and less than 2/3 of the test piece. Mycelial elongation is observed in more than 2/3 of the specimens

Figure 2008163011
Figure 2008163011

Figure 2008163011
Figure 2008163011

Claims (3)

フェニルイミダゾール化合物のN−アルキル変性物であり、当該アルキル基の炭素数が5以上であることを特徴とする殺菌性化合物。   A bactericidal compound, which is an N-alkyl modified product of a phenylimidazole compound, wherein the alkyl group has 5 or more carbon atoms. 前記アルキル基の炭素数が6〜12である請求項1記載の殺菌性化合物。   The bactericidal compound according to claim 1, wherein the alkyl group has 6 to 12 carbon atoms. 請求項1または請求項2記載の殺菌性化合物を有効成分として含む殺菌性組成物。   A bactericidal composition comprising the bactericidal compound according to claim 1 or 2 as an active ingredient.
JP2007311841A 2006-12-06 2007-12-01 Bactericidal composition Expired - Fee Related JP5207716B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2007311841A JP5207716B2 (en) 2006-12-06 2007-12-01 Bactericidal composition

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2006328881 2006-12-06
JP2006328881 2006-12-06
JP2007311841A JP5207716B2 (en) 2006-12-06 2007-12-01 Bactericidal composition

Publications (2)

Publication Number Publication Date
JP2008163011A true JP2008163011A (en) 2008-07-17
JP5207716B2 JP5207716B2 (en) 2013-06-12

Family

ID=39692958

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007311841A Expired - Fee Related JP5207716B2 (en) 2006-12-06 2007-12-01 Bactericidal composition

Country Status (1)

Country Link
JP (1) JP5207716B2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105777642A (en) * 2014-12-16 2016-07-20 中国科学院大连化学物理研究所 N1 position-substituted imidazole compound and alkaline anion exchange membrane, and preparation methods thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3531494A (en) * 1965-07-22 1970-09-29 Heinrich Adolphi Monohydroxy alkyl imidazoles
JPS52102426A (en) * 1976-02-24 1977-08-27 Sakai Chem Ind Co Ltd Bacteriostatic and fungi-static composition
US4411700A (en) * 1980-10-17 1983-10-25 Fuji Photo Film Co., Ltd. Desensitizer compositions
JP2007051248A (en) * 2005-08-19 2007-03-01 Kyocera Chemical Corp Electroconductive adhesive composition

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3531494A (en) * 1965-07-22 1970-09-29 Heinrich Adolphi Monohydroxy alkyl imidazoles
JPS52102426A (en) * 1976-02-24 1977-08-27 Sakai Chem Ind Co Ltd Bacteriostatic and fungi-static composition
US4411700A (en) * 1980-10-17 1983-10-25 Fuji Photo Film Co., Ltd. Desensitizer compositions
JP2007051248A (en) * 2005-08-19 2007-03-01 Kyocera Chemical Corp Electroconductive adhesive composition

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
JPN6012037692; Chemical Abstracts Vol.113, No.11, p.701 (1990). *
JPN6012037694; Chemical Abstracts Vol.114, No.11, p.734 (1991). *
JPN6012037696; Chemical Abstracts Vol.117, No.23, p.866 (1992). *
JPN6012037698; Chemical Abstracts Vol.120, No.19, p.1019 (1994). *

Also Published As

Publication number Publication date
JP5207716B2 (en) 2013-06-12

Similar Documents

Publication Publication Date Title
WO1987003591A1 (en) Novel imidazole derivatives, bactericides containing them, and process for their preparation
EP0221781A2 (en) Benzylamine derivatives, process for production thereof, and use thereof
JP5207716B2 (en) Bactericidal composition
JPS59112904A (en) Fungicide
EP2432767B1 (en) Compounds and methods for controlling fungi
JP5207715B2 (en) Bactericidal composition
CN1033389C (en) Biocidal compositions
JP5398177B2 (en) Bactericidal composition
KR102578908B1 (en) Antifungal agents containing trifluoromethylated hydroquinone derivatives
CN108059613B (en) Pyrazole amide compound and application thereof
CS197319B2 (en) Fungicide means and method of production of active agents
US4339453A (en) Antimicrobial aminopyrimidinium salts
DK165553B (en) IMIDAZOLD DERIVATIVES, PROCEDURES FOR PREPARING THEM AND USING THESE AS FUNGICIDES
JP2003267953A (en) Bis type quaternary ammonium salt compound and antimicrobial agent
DE2105174B2 (en) 8-Oxychinolin- and 8-Oxy quinaldinacrylate, process for their preparation and means for combating microorganisms
IL40271A (en) 2-amino-6-sulphamyl-pyrimidine derivatives and fungicidal compositions containing them
FI59997C (en) NYA 2-BENZIMIDAZOLE-CARBAMINE SYRESTERTERER WITH MEDICAL THERAPEUTIC FUNGICID OCH OVICID NETWORK
JPS60228443A (en) Beta-naphthylalkylamines
US20040002545A1 (en) Thiazole derivatives of 2-methoxyimino-2-(pyridinyloxymethyl)-phenyl-acetamides useful as fungicides
JP3138768B2 (en) Novel dimer-type quaternary ammonium salt compound and method for producing the same
US3651088A (en) Certain anilinoalkyl mercaptans as fungicides
JP5352255B2 (en) Quinoxaline compound or salt thereof, and industrial bactericidal composition
US3175941A (en) Method of combatting powdery mildew with paraaminobenzoic and cinnamic acid esters
JP2584807B2 (en) Maleimide derivative, process for producing the same, and agricultural / horticultural fungicide containing the same as an active ingredient
KR101665231B1 (en) Thiazole derivatives having thiophenyl group and fungicides containing the same

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20101013

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20120629

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120720

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120809

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20130208

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20130219

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20160301

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Ref document number: 5207716

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees